Xcout Intel
VelosBio competitors & alternatives
The 12 closest competitors and alternatives to VelosBio among biotechnology companies — ranked by similarity to what VelosBio actually does, not by market-cap band.
Subscribe to see VelosBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About VelosBio
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
VelosBio at a glance
VelosBio is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $137M in July 2020. Xcout tracks 1 named person at VelosBio, including Rob Davis (chairman of the board and chief executive officer).
VelosBio leadership
- Rob Davischairman of the board and chief executive officer
VelosBio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $137M | 14 named | |
| Series A | $59.3M | 6 named | |
| SEC Form D filing | $6.5M | — | |
| SEC Form D filing | $7.7M | — | |
| Series A | $58M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 VelosBio competitors
Ranked by semantic similarity — how close each company is to VelosBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotechnology company
Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with supplementary operations in Boston, Massachusetts. The company specializes in the development of innovative antibody-drug conjugates (ADCs) targeting various oncology indications. Its pipeline focuses on delivering best-in-class clinical treatments for patients with high unmet medical needs.
Similar biotechnology company
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Biotech
Adcytherix is a clinical-stage biopharmaceutical company that develops next-generation antibody-drug conjugates (ADCs) for oncology. The company combines clinically validated targets with innovative payloads derived from approved cancer drugs to treat resistant cancers and address unmet medical needs.
Similar biotechnology company
Centrose LLC is a biotechnology company that develops a next-generation antibody-drug conjugate platform known as Extracellular Drug Conjugates (EDCs). These precision medicines target the cell surfaceome by binding multiple extracellular proteins simultaneously without cell internalization or drug release, aiming to create safer and more potent treatments for cancer and drug-resistant tumors.
Biotech
Coherus BioSciences, Inc. is a biopharmaceutical company headquartered in Redwood City, California, focused on oncology and developing innovative therapeutics.
Similar biotechnology company
NBE-Therapeutics is a biotechnology company founded in 2012 and headquartered in Basel, Switzerland, focused on developing antibody-drug conjugates for oncology treatments.
Similar biotechnology company
Catena Biosciences is a biotechnology company based in Berkeley, California, that pioneers protein conjugation technologies for novel therapeutics. Founded in 2020, the company builds upon technology developed in labs at the University of California, Berkeley.
Similar biotechnology company
Pheon Therapeutics is a biotechnology research company headquartered in London, England, that specializes in developing next-generation antibody-drug conjugates for hard-to-treat cancers.
Similar biotechnology company
92Bio is a clinical-stage biotechnology company headquartered in Hayward, California, that develops next-generation T-cell engaging antibodies for therapeutic treatments.
Similar biotechnology company
Fortis Therapeutics is an immuno-oncology biotechnology research company founded in 2010 and headquartered in La Jolla, California. The company focuses on developing novel antibody drug conjugate therapies targeting CD46 for cancer treatment.
Biotech
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of VelosBio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for VelosBioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →